Seven Mile Advisory’s Amgen AMGN Stock Holding History

Seven Mile Advisory’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$364K	Sell	1,004 -473	-32%	-$162K	0.24%	86
2026 Q1	$520K	Sell	1,477 -600	-29%	-$214K	0.38%	54
2025 Q4	$680K	Buy	2,077 +538	+35%	+$171K	0.12%	90
2025 Q3	$434K	Buy	1,539 +687	+81%	+$199K	0.07%	147
2025 Q2	$238K	Sell	852 -39	-4%	-$11K	0.14%	145
2025 Q1	$278K	Buy	+891	New	+$263K	0.19%	124
2024 Q4	–	Sell	-949	Closed	-$306K	–	170
2024 Q3	$306K	Buy	949 +97	+11%	+$31.7K	0.2%	104
2024 Q2	$266K	Buy	852 +113	+15%	+$33.2K	0.2%	108
2024 Q1	$210K	Buy	739 +16	+2%	+$4.68K	0.16%	143
2023 Q4	$208K	Sell	723 -60	-8%	-$16.3K	0.18%	136
2023 Q3	$210K	Buy	+783	New	+$195K	0.22%	108

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Seven Mile Advisory's AMGN Position: Q2 2026 in Review

Seven Mile Advisory reduced its Amgen (AMGN) stake by 32% in Q2 2026, selling an estimated $162K and leaving 1,004 shares worth $364K. The position accounts for 0.24% of the portfolio, ranked #86.

Seven Mile Advisory first reported a position in AMGN in Q3 2023 and has held it in 11 quarters since. The position peaked at $680K in Q4 2025. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Seven Mile Advisory held 1,004 shares of Amgen worth $364K as of Q2 2026.
Seven Mile Advisory sold 473 Amgen shares in Q2 2026, an estimated $162K.
Amgen made up 0.24% of Seven Mile Advisory's portfolio in Q2 2026, its #86 holding.
Seven Mile Advisory first reported a position in Amgen in Q3 2023 and has held it in 11 quarters since.
Seven Mile Advisory's Amgen position peaked at $680K in Q4 2025.
3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Seven Mile Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.